Literature DB >> 14639539

Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine.

M Catherine McEllistrem1, Jennifer Adams, Edward O Mason, Ellen R Wald.   

Abstract

We studied, by pulsed-field gel electrophoresis, multilocus sequence typing and penicillin-binding protein 2b amplicon-restriction profiles, pneumococcal isolates recovered from children with acute otitis media during 1 January-31 December 1999 and 2001. The proportion of nonvaccine serogroups increased from 14.8% (13/88) to 36.5% (23/63) from 1999 to 2001 (P<.01). Among children who received at least 2 doses of the pneumococcal 7-valent protein conjugate (PNC7) vaccine, 46.7% (7/15) of the isolates had nonvaccine serogroups, compared with 20.8% (26/125) of the isolates from children who did not receive the PNC7 vaccine (P=.05). Overall, the serogroups involved in capsular switching were 6-19-NT, 6-14-35, 15-19, and the 19-Spanish 23F clone. In 1999 and 2001, 30.8% (4/13) and 26.1% (6/23) of the nonvaccine serogroups were implicated in capsular switching, respectively. Continued surveillance will be of great importance as the distribution of the PNC7 vaccine increases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14639539     DOI: 10.1086/379665

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  Vaccine-induced pathogen strain replacement: what are the mechanisms?

Authors:  Maia Martcheva; Benjamin M Bolker; Robert D Holt
Journal:  J R Soc Interface       Date:  2008-01-06       Impact factor: 4.118

2.  Genetic relatedness of Streptococcus pneumoniae isolates from paired blood and respiratory specimens.

Authors:  L J Harrell; S K Sharps; R A Bean; L B Reller
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

3.  Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection.

Authors:  John P Leeming; Keith Cartwright; Rhonwen Morris; Siobhan A Martin; Michael D Smith
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 4.  Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany.

Authors:  M van der Linden; R R Reinert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-30       Impact factor: 3.267

5.  Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins.

Authors:  Josée Hamel; Nathalie Charland; Isabelle Pineau; Catherine Ouellet; Stéphane Rioux; Denis Martin; Bernard R Brodeur
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

6.  New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.

Authors:  Janet R Casey; Diana G Adlowitz; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

7.  Competitive inhibition flow analysis assay for the non-culture-based detection and serotyping of pneumococcal capsular polysaccharide.

Authors:  H Findlow; G Laher; P Balmer; C Broughton; E D Carrol; R Borrow
Journal:  Clin Vaccine Immunol       Date:  2008-12-17

8.  Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis media.

Authors:  Isabelle Hau; Corinne Levy; Laurence Caeymaex; Robert Cohen
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

9.  Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002.

Authors:  Bernard Beall; M Catherine McEllistrem; Robert E Gertz; Stephanie Wedel; David J Boxrud; Antonio L Gonzalez; Marie-Jo Medina; Rekha Pai; Terry A Thompson; Lee H Harrison; Lesley McGee; Cynthia G Whitney
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine.

Authors:  Alison S Laufer; Jonathan C Thomas; Marisol Figueira; Janneane F Gent; Stephen I Pelton; Melinda M Pettigrew
Journal:  Vaccine       Date:  2010-01-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.